Static Image
Help Us Fight for 50 During Arthritis Awareness Month!

Help Us Fight for 50 During Arthritis Awareness Month!

May is National Arthritis Awareness Month, and this month, we’re asking you to join us in our fight for the more than 50 million Americans with arthritis. Arthritis is the number one cause of disability in the country. This means that 1 in every 4 adults, more than 300,000 children and countless families and loved ones are affected by arthritis. So how can you help? We want you to tell us your story. Tell us why you fight – about the struggles you face and the daily challenges you overcome. Tell us why you strive to be a Champion of Yes or ...more
Arthritis Foundation Investigator Developing Arthritis Vaccine

Arthritis Foundation Investigator Developing Arthritis Vaccine

In February, we reported on Dr. Farshid Guilak’s current Arthritis Foundation-funded trailblazing project, “Engineering New Biologic Therapies for Arthritis.” On May 9, Dr. Guilak’s work will be published in the journal Stem Cell Reports. The paper, entitled “Genome engineering of stem cells for autonomously regulated, closed-loop delivery of biologic drugs,” describes the research team’s method of engineering (reprogramming) stem cells to become “smart stem cells” that will sense inflammation and deliver biologic drugs where they are most needed. The smart stem cells-biologic drug combination is then injected into an arthritic joint. “Our goal is to package the rewired stem cells as a ...more
Heart Disease Risk May be Nearly Doubled in People with Psoriatic Arthritis

Heart Disease Risk May be Nearly Doubled in People with Psoriatic Arthritis

Doctors have long known that heart disease is more common in people who have inflammatory conditions such as rheumatoid arthritis (RA) and psoriasis. But they weren’t sure if this applied to psoriatic arthritis (PsA), which is more complex and not nearly as well studied. Then, in 2016, Canadian researchers published a meta-analysis of studies evaluating cardiovascular disease risk and PsA in the journal Arthritis Care & Research. The results suggested that people with PsA were 43 percent more likely to have or develop heart disease compared with the general population. PsA patients also had a 22 percent increased risk of ...more
Increasing Allopurinol Dose May Better Control Gout

Increasing Allopurinol Dose May Better Control Gout

In addition to being treated with medication for symptoms of an acute flare, should a person with gout be put on long-term uric acid-lowering medication to reduce future flares? And is it safe to keep raising the dose of the medication until uric acid drops below a specified target? Rheumatologists and other physicians are currently grappling with those questions, and a new study may help lead to some answers. What Is Gout? Gout is the most common form of inflammatory arthritis in the United States, affecting more than 8 million adults. It develops in some people who have high levels of uric acid ...more
The Nation’s Capital Caps the Out-of-Pocket Costs of Medications

The Nation’s Capital Caps the Out-of-Pocket Costs of Medications

Congratulations D.C. Advocates! Because of your efforts, Washington, D.C. Mayor Muriel Bowser signed the Specialty Drug Copayment Limitation Act. In the law, “specialty drug” means a prescription drug that is prescribed for a person with a physical, behavioral, or developmental condition that may have no known cure, is progressive, or can be debilitating or fatal if left untreated or undertreated, such as multiple sclerosis, hepatitis C and rheumatoid arthritis. This is a significant win for the Washington D.C. arthritis community because the law caps specialty drug copayment or coinsurance out-of-pocket costs to no more than $150 for up to a 30-day ...more
Up Close and Personal with our Walk to Cure Arthritis National Adult Honoree Tom Walker

Up Close and Personal with our Walk to Cure Arthritis National Adult Honoree Tom Walker

As a believer in living a full life and being a Champion of Yes, we asked Tom Walker – who has experienced highs and lows and endured it all – a few lighthearted, personal questions. When did you realize you wanted to play baseball professionally? Growing up in Florida, there were several great baseball players. I was around baseball a lot and loved it. I couldn’t think of doing anything else. I thought if things went well, maybe I could play in the big leagues, which I did in 1972 when I joined the Montreal Expos. Do you think your willpower ...more
Champions of Yes: Amy and Kylie McCormick Form a Dynamic Duo to Tackle Juvenile Arthritis

Champions of Yes: Amy and Kylie McCormick Form a Dynamic Duo to Tackle Juvenile Arthritis

When you meet Amy McCormick and her daughter, Kylie, of Hauppauge, New York, you instantly feel as though you’ve known them for years. They both consistently greet you with warm smiles and joyful hellos, chatting about their love of Hamilton, the arts and their newly adopted rescue puppy named Autumn. Kylie was only seven years old when she was performing in a year-round production of Annie, acting and dancing heavily through rehearsals and plays week after week. Kylie started experiencing foot and ankle pain so severe she couldn’t walk, and eventually told her mother she couldn’t attend rehearsals. Alarmed by Kylie’s ...more
Researchers on the Path to a Cure - Spotlight on Dr. Tuhina Neogi

Researchers on the Path to a Cure - Spotlight on Dr. Tuhina Neogi

If you have osteoporosis you’ve probably heard of, and may have been treated with, a class of drugs that are used to prevent and treat bone loss: bisphosphonates. Dr. Tuhina Neogi and her research team are using new methods to look at how the long-term effects of using these drugs may be related to the progression of knee osteoarthritis (OA). Dr. Neogi’s 2-year Arthritis Foundation-funded project, “Bisphosphonate Effects in Knee Osteoarthritis,” is looking at the relationship of bisphosphonate treatment and the structural changes in the knee associated with OA progression. To do this, Dr. Neogi and her team are looking at ...more
Wrong Hydroxychloroquine Dose Is Common, Putting Eyes at Risk

Wrong Hydroxychloroquine Dose Is Common, Putting Eyes at Risk

Up to half of patients treated with the arthritis drug hydroxychloroquine (Plaquenil) are prescribed more than the recommended maximum amount, according to new research. In separate studies, Canadian and U.S. researchers found that 30 to 50 percent of patients didn’t receive the dose outlined in treatment guidelines; a smaller percentage didn’t get recommended eye exams. Hydroxychloroquine is an antimalarial drug commonly used to treat rheumatoid arthritis (RA), lupus and other autoimmune diseases, either alone or as a part of combination therapy. Unlike some of the other traditional disease-modifying antirheumatic drugs (DMARDs) and biologics, it affects the immune response without suppressing the ...more
Pedal For A Purpose – The Arthritis Foundation’s Bike Classic Events

Pedal For A Purpose – The Arthritis Foundation’s Bike Classic Events

The Arthritis Foundation is proud to host signature events across the country such as the Walk to Cure Arthritis and Jingle Bell Run. However, if walking or running isn’t in your repertoire, we also host four different Arthritis Bike Classic events – all of them currently held on the west coast in Oregon and California – though riders have come from near and far to take part in these wonderful events. In an article about cycling, the Arthritis Foundation YES tool says, “Cycling offers efficient, low-impact exercise for millions of Americans. It is a good cardiovascular exercise that strengthens leg muscles ...more